Addition of [18F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross‐Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma
Binu V. John, Sean Aubuchon, Bassam Dahman, Venkata Rajesh Konjeti, Douglas Heuman, Jennifer Hubert, Smitha Thomas, Yangyang Deng, Cynthia Solomon, Latha Thankam Sundaram, Eleanor Love, Amit G. Singal, James L. Tatum – 3 March 2020 – In this work, we characterize the value of positron emission tomography (PET) with computed tomography (CT) in combination with cross‐sectional imaging for staging and prognostication of hepatocellular carcinoma (HCC) patients.